Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2929
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01523171 | Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib | ||
| NCT00135434 | Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism | ||
| NCT04305249 | Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies | ||
| NCT02427516 | Cost of Monitoring Patients Treated With Vitamin K Antagonists in Spain | ||
| NCT01642004 | Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) | ||
| NCT01024101 | Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer | ||
| NCT05064436 | A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis | ||
| NCT03667716 | COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. | ||
| NCT05044533 | A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF) | ||
| NCT02068053 | Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020 | ||
| NCT02863523 | COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes | ||
| NCT03930602 | Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165 | ||
| NCT00252564 | Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer | ||
| NCT07636863 | Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig | ||
| NCT03285321 | Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) | ||
| NCT04825873 | A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China | ||
| NCT02050594 | Ipilimumab 12-month Intensive Pharmacovigilance Protocol | ||
| NCT00928031 | Long-term Data Collection for Subjects in MDX-010 Studies | ||
| NCT02097966 | EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C | ||
| NCT04925375 | Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease | ||
| NCT00399906 | A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis | ||
| NCT04918147 | Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) | ||
| NCT04735978 | Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours | ||
| NCT00036621 | A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy | ||
| NCT00130806 | An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) | ||
| NCT00246987 | A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control | ||
| NCT02655458 | Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma | ||
| NCT00116415 | DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy | ||
| NCT04003649 | IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM | ||
| NCT02992964 | Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers | ||
| NCT02792335 | Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients | ||
| NCT03083691 | BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer | ||
| NCT00979368 | Safety Study of BMS-816336 in Healthy Male Subjects | ||
| NCT05284890 | A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants | ||
| NCT06971185 | A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept | ||
| NCT00792558 | Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers | ||
| NCT05382715 | A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis | ||
| NCT01766817 | Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis | ||
| NCT01052389 | Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia | ||
| NCT04709276 | A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer | ||
| NCT00729664 | Multiple Ascending Dose (MDX1105-01) | ||
| NCT00924898 | Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) | ||
| NCT03126643 | Expanded Access to Nivolumab (Opdivo) | ||
| NCT05413018 | An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission | ||
| NCT02095860 | Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 | ||
| NCT07008820 | Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan | ||
| NCT00554450 | Renal Impairment in Type 2 Diabetic Subjects | ||
| NCT01129388 | Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects | ||
| NCT00744497 | Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer | ||
| NCT00279760 | Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis |
